Researchers present first complete control map for KRAS, laying out a fresh blueprint for targeting ‘undruggable’ proteins. Researchers at the Centre for Genomic Regulation in Barcelona, Spain, and the Wellcome Sanger Institute near Cambridge, UK, have comprehensively identified the allosteric co
English (US) ·